Myocardial infarction survivors have an increased risk of stroke, which is reduced with long-term anticoagulant therapy. However, an estimated 10-times increase in risk of bleeding during such treatment has been reported. We evaluated the risk of stroke in patients after a myocardial infarction and
Long-term survival of chronic dialysis patients in comparison to that of stroke and acute myocardial infarction patients
β Scribed by K. Iseki; K. Wakugami; A. Maehara; M. Tozawa; H. Muratani; K. Fukiyama
- Publisher
- Springer
- Year
- 2001
- Tongue
- English
- Weight
- 82 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1342-1751
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Purpose To assess the safety data from two large, multicenter, phase 2 trials on the use of gadoversetamide (OptiMARK, Tyco Healthcare/Mallinckrodt, St. Louis, MO) as a contrast agent in delayed hyperenhancement magnetic resonance imaging (DEβMRI) in patients with acute and chronic
## Abstract Background: Cardiogenic shock (CS) is a severe complication of acute myocardial infarction (AMI), associated with a high mortality. A significant improvement in survival has been reported with immediate coronary revascularization. However, there is no clear evidence of such an improveme
Primary percutaneous coronary intervention (PCI) for ST segment elevation myocardial infarction (STEMI) due to saphenous vein graft (SVG) occlusion has been associated with poor procedural results and poor short-term outcomes, but long-term graft patency and patient survival have not been evaluated.